• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素和广泛研究的 TNF-α 在非霍奇金淋巴瘤中的作用。

The role of interleukins and the widely studied TNF-α in non-Hodgkin's lymphoma.

机构信息

Department of Microbiology, Immunology and Pathology, Des Moines University College of Osteopathic Medicine, Des Moines, IA, 50312, USA.

The Department of Respiratory Medicine, The 2nd People's Hospital of Hefei and Hefei Hospital Affiliated to Anhui Medical University, Hefei, China.

出版信息

Med Oncol. 2021 Apr 9;38(5):56. doi: 10.1007/s12032-021-01504-y.

DOI:10.1007/s12032-021-01504-y
PMID:33835307
Abstract

Non-Hodgkin's lymphoma is a relatively common cancer with malignant tendencies. Although there is no current cure for the disease, research has been successful in figuring out the mechanisms of how the disease progresses, however, there is still a lot of unknowns, and more research must be done to find the ultimate cause of the disease. Interleukins and various cytokines play unique roles in the development of cancer. This review article summarizes the pathophysiology between certain interleukins and non-Hodgkin's lymphoma. Although TNF-α is not an interleukin, the article examines TNF-α due to its high correspondence with cancer. The article also describes a promising immunotherapy for the disease, while looking at immunotherapies that have been successful in other types of cancer and disease.

摘要

非霍奇金淋巴瘤是一种相对常见的具有恶性倾向的癌症。虽然目前还没有治愈这种疾病的方法,但研究已经成功地揭示了疾病进展的机制,但仍有许多未知因素,需要进一步研究以找到疾病的根本原因。白细胞介素和各种细胞因子在癌症的发展中发挥着独特的作用。本文综述了某些白细胞介素与非霍奇金淋巴瘤之间的病理生理学关系。虽然 TNF-α 不是白细胞介素,但由于它与癌症有很高的对应关系,本文也对 TNF-α 进行了研究。本文还描述了一种有前途的非霍奇金淋巴瘤免疫疗法,同时探讨了在其他类型的癌症和疾病中成功应用的免疫疗法。

相似文献

1
The role of interleukins and the widely studied TNF-α in non-Hodgkin's lymphoma.白细胞介素和广泛研究的 TNF-α 在非霍奇金淋巴瘤中的作用。
Med Oncol. 2021 Apr 9;38(5):56. doi: 10.1007/s12032-021-01504-y.
2
Advances in the management of Hodgkin's and non-Hodgkin's lymphoma.霍奇金淋巴瘤和非霍奇金淋巴瘤的管理进展
Curr Opin Hematol. 1998 Jul;5(4):259-63. doi: 10.1097/00062752-199807000-00005.
3
Adoptive immunotherapy for Hodgkin's lymphoma.霍奇金淋巴瘤的过继性免疫治疗
Int J Hematol. 2006 Jun;83(5):385-90. doi: 10.1532/IJH97.06107.
4
[Immunohistochemical in situ demonstration of cytokines in Hodgkin and non-Hodgkin lymphoma].[霍奇金淋巴瘤和非霍奇金淋巴瘤中细胞因子的免疫组织化学原位显示]
Verh Dtsch Ges Pathol. 1992;76:164-8.
5
Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms.淋巴瘤患者血清白细胞介素6水平升高,且与晚期霍奇金病的生存率及B症状相关。
Cancer Res. 1993 May 1;53(9):2118-22.
6
Cytokine production (IL-1 alpha, IL-1 beta, and TNF alpha) and endothelial cell activation (ELAM-1 and HLA-DR) in reactive lymphadenitis, Hodgkin's disease, and in non-Hodgkin's lymphomas. An immunocytochemical study.反应性淋巴结炎、霍奇金病及非霍奇金淋巴瘤中细胞因子产生(白细胞介素-1α、白细胞介素-1β和肿瘤坏死因子α)及内皮细胞活化(E-选择素和人类白细胞抗原-DR):一项免疫细胞化学研究
Am J Pathol. 1990 Nov;137(5):1163-71.
7
Infusions of interleukin-1 alpha after autologous transplantation for Hodgkin's disease and non-Hodgkin's lymphoma induce effector cells with antilymphoma cytolytic activity.霍奇金淋巴瘤和非霍奇金淋巴瘤自体移植后输注白细胞介素-1α可诱导产生具有抗淋巴瘤细胞溶解活性的效应细胞。
J Clin Immunol. 1994 May;14(3):205-11. doi: 10.1007/BF01533369.
8
Current advances, problems and prospects for vaccine-based immunotherapy in follicular non-Hodgkin's lymphoma.滤泡性非霍奇金淋巴瘤中基于疫苗的免疫疗法的当前进展、问题与前景
Leuk Lymphoma. 2005 Apr;46(4):497-507. doi: 10.1080/104281904000025104.
9
Drug evaluation: FavId, a patient-specific idiotypic vaccine for non-Hodgkin's lymphoma.药物评估:FavId,一种用于非霍奇金淋巴瘤的个体化独特型疫苗。
Curr Opin Mol Ther. 2007 Jun;9(3):291-8.
10
Production of interleukin-1 and tumour necrosis factor in non-Hodgkin's lymphoma patients.非霍奇金淋巴瘤患者白细胞介素-1和肿瘤坏死因子的产生
Cancer Immunol Immunother. 1991;34(2):123-7. doi: 10.1007/BF01741346.

引用本文的文献

1
Circulating Biomarker Panorama in HIV-Associated Lymphoma: A Bridge from Early Risk Warning to Prognostic Stratification.HIV相关淋巴瘤中的循环生物标志物全景:从早期风险预警到预后分层的桥梁
Biomolecules. 2025 Jul 11;15(7):993. doi: 10.3390/biom15070993.
2
New horizons in B-cell lymphoma immunotherapy: From immune checkpoints to precision medicine.B细胞淋巴瘤免疫治疗的新视野:从免疫检查点到精准医学
Neoplasia. 2025 Jun 30;67:101206. doi: 10.1016/j.neo.2025.101206.
3
Exploring risk factors for autoimmune diseases complicated by non-hodgkin lymphoma through regulatory T cell immune-related traits: a Mendelian randomization study.

本文引用的文献

1
The Role of Interleukin-9 in Cancer.白细胞介素-9 在癌症中的作用。
Pathol Oncol Res. 2020 Oct;26(4):2017-2022. doi: 10.1007/s12253-019-00665-6. Epub 2019 Apr 23.
2
Markers of Inflammation and Infection in Sepsis and Disseminated Intravascular Coagulation.脓毒症和弥散性血管内凝血中的炎症和感染标志物。
Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029619843338. doi: 10.1177/1076029619843338.
3
CD8 cytotoxic T lymphocytes in cancer immunotherapy: A review.癌症免疫治疗中的 CD8 细胞毒性 T 淋巴细胞:综述。
通过调节性 T 细胞免疫相关特征探讨自身免疫性疾病并发非霍奇金淋巴瘤的危险因素:一项孟德尔随机研究。
Front Immunol. 2024 May 28;15:1374938. doi: 10.3389/fimmu.2024.1374938. eCollection 2024.
4
Assessment and prognostic significance of a serum cytokine panel in diffuse large B‑cell lymphoma.弥漫性大B细胞淋巴瘤血清细胞因子谱的评估及其预后意义
Oncol Lett. 2024 Mar 28;27(5):237. doi: 10.3892/ol.2024.14370. eCollection 2024 May.
5
Genetically Engineered-Cell-Membrane Nanovesicles for Cancer Immunotherapy.基因工程细胞膜纳米囊泡用于癌症免疫治疗。
Adv Sci (Weinh). 2023 Sep;10(26):e2302131. doi: 10.1002/advs.202302131. Epub 2023 Jul 6.
6
IL-6 and IL-10 Are Associated With Gram-Negative and Gram-Positive Bacteria Infection in Lymphoma.IL-6 和 IL-10 与淋巴瘤中革兰氏阴性菌和革兰氏阳性菌感染有关。
Front Immunol. 2022 Apr 1;13:856039. doi: 10.3389/fimmu.2022.856039. eCollection 2022.
J Cell Physiol. 2019 Jun;234(6):8509-8521. doi: 10.1002/jcp.27782. Epub 2018 Nov 22.
4
Interleukin 30 to Interleukin 40.白细胞介素 30 至白细胞介素 40。
J Interferon Cytokine Res. 2018 Oct;38(10):423-439. doi: 10.1089/jir.2018.0089.
5
Tumor-related interleukins: old validated targets for new anti-cancer drug development.肿瘤相关白细胞介素:新抗癌药物开发的旧有验证靶点。
Mol Cancer. 2017 Sep 19;16(1):153. doi: 10.1186/s12943-017-0721-9.
6
Pediatric Lymphoma.小儿淋巴瘤
Pediatr Rev. 2017 Sep;38(9):410-423. doi: 10.1542/pir.2016-0152.
7
The role of IL-7 in Immunity and Cancer.白细胞介素-7在免疫与癌症中的作用。
Anticancer Res. 2017 Mar;37(3):963-967. doi: 10.21873/anticanres.11405.
8
Unveil the mysterious mask of cytokine-based immunotherapy for melanoma.揭开基于细胞因子的黑色素瘤免疫疗法的神秘面纱。
Cancer Lett. 2017 May 28;394:43-51. doi: 10.1016/j.canlet.2017.02.022. Epub 2017 Feb 28.
9
Non-Hodgkin lymphoma.非霍奇金淋巴瘤。
Lancet. 2017 Jul 15;390(10091):298-310. doi: 10.1016/S0140-6736(16)32407-2. Epub 2017 Jan 31.
10
Non-Hodgkin lymphoma across the pediatric and adolescent and young adult age spectrum.儿童、青少年及青年各年龄段的非霍奇金淋巴瘤。
Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):589-597. doi: 10.1182/asheducation-2016.1.589.